Abstract
Hepatocellular carcinoma (HCC) is a primary liver neoplasm that originates in hepatocytes caused by hepatitis B and C virus infections, which are the major etiologic causes of HCC, either through carcinogenesis or cirrhosis. Most of the patients undergoing therapy have the option of treatment with sorafenib, a drug-target multi-kinase inhibitor treatment; however, drug resistance is still…